MARKET

TBIO

TBIO

TRANSLATE BIO, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.99
-0.18
-1.05%
After Hours: 17.05 +0.06 +0.35% 19:07 07/10 EDT
OPEN
17.12
PREV CLOSE
17.17
HIGH
17.33
LOW
16.82
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
28.09
52 WEEK LOW
6.80
MARKET CAP
1.12B
P/E (TTM)
-9.7936
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TBIO stock price target is 32.29 with a high estimate of 40.00 and a low estimate of 29.00.

EPS

TBIO News

More
Translate Bio Is Much More Than Just A Covid-19 Vaccine Biotech
Seeking Alpha - Article · 1d ago
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio
Zacks · 2d ago
William Blair Initiates Coverage On Translate Bio with Outperform Rating
William Blair initiates coverage on Translate Bio (NASDAQ:TBIO) with a Outperform rating.
Benzinga · 4d ago
Heron Therapeutics (HRTX) in Focus: Stock Moves 9% Higher
Zacks · 07/03 03:38
Seth Klarman Ups Stake in Translate Bio
GuruFocus.com · 07/01 23:03
Insider Buys Translate Bio's Shares
Benzinga · 07/01 15:35
Moderna: Trading In A COVID-19 Bubble - 70% Downside
Seeking Alpha - Article · 07/01 13:45
Coronavirus Vaccine Update, June 29
Seeking Alpha - Article · 06/30 13:59

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About TBIO

Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization.
More

Webull offers kinds of Translate Bio Inc stock information, including NASDAQ:TBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TBIO stock methods without spending real money on the virtual paper trading platform.